Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost …

M Walton, L Bojke, M Simmonds, R Walker, A Llewellyn… - Value in Health, 2024 - Elsevier
Objectives This study aimed to evaluate the cost-effectiveness of anti–vascular endothelial
growth factor drugs (anti-VEGFs) compared with panretinal photocoagulation (PRP) for …

Anti-VEGF Drugs Compared with Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

M Walton, L Bojke, M Simmonds, R Walker… - Value in …, 2024 - openaccess.city.ac.uk
Objective To evaluate the cost-effectiveness of anti-vascular endothelial growth factor drugs
(anti-VEGFs) compared with panretinal photocoagulation (PRP) for treating proliferative …